Patents by Inventor Steven N. Anderson

Steven N. Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel amides that activate soluble guanylate cyclase
    Publication number: 20040192680
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: December 18, 2003
    Publication date: September 30, 2004
    Inventors: Steven N. Anderson, Pramila A. Bhatia, Teodozyj Kolasa, Masaki Nakane, Meena V. Patel, Jeffrey J. Rohde, Xia Zhiren, Henry Qing-Wei Zhang
  • Novel amides that activate soluble guanylate cyclase
    Publication number: 20040121994
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: December 20, 2002
    Publication date: June 24, 2004
    Inventors: Steven N. Anderson, Pramila Bhatia, Teodozyj Kolasa, Masaki Nakane, Meena V. Patel, Jeffrey J. Rohde, Zhiren Xia, Henry Q. Zhang
  • Nutritional formulations containing water-miscible lipid derivatives as antibacterial agents
    Patent number: 6228886
    Abstract: A nutritional formulation containing bactericidal amounts of diacetyltartaric acid esters of mono- and diglycerides is provided. A process of inhibiting bacterial infections including the step of feeding the nutritional composition to a subject is also provided.
    Type: Grant
    Filed: May 22, 2000
    Date of Patent: May 8, 2001
    Assignee: Abbott Laboratories
    Inventors: Steven N. Anderson, Milo Duane Hilty, Terry Bruce Mazer, Joseph Schaller, Melinda Guzman-Harty, Theresa Siu-Ling Wai Lee, Lisa Ann Reaves, Jin-Zhou Liu
  • Water-Miscible esters of mono- and diglycerides having antimicrobial activity and their use in inhibiting infection
    Patent number: 6136855
    Abstract: A process of treating infection by a pathogenic microorganism in a subject in need of such treatment comprising the step of administering to the subject an effective antimicrobial amount of diacetyltartaric acid esters of mono- and diglycerides is provided. Pharmaceutical compositions containing diacetyltartaric acid esters of mono- and diglycerides as an active antimicrobial agent are also provided.
    Type: Grant
    Filed: July 16, 1999
    Date of Patent: October 24, 2000
    Assignee: Abbott Laboratories
    Inventors: Melinda Guzman-Harty, Milo Duane Hilty, Steven N. Anderson, Joseph Schaller, Terry Bruce Mazer, Theresa Siu-Ling Wai Lee, Lisa Ann Reaves, Jin-Zhou Liu
  • Nutritional formulations containing water-miscible lipid derivatives as anti-bacterial agents
    Patent number: 6066669
    Abstract: A nutritional formulation containing bacterial amounts of diacetyltartaric acid esters of mono- and diglycerides is provided. A process of inhibiting bacterial infections including the step of feeding the nutritional composition to a subject is also provided.
    Type: Grant
    Filed: April 16, 1999
    Date of Patent: May 23, 2000
    Assignee: Abbott Laboratories
    Inventors: Steven N. Anderson, Milo Duane Hilty, Terry Bruce Mazer, Joseph Schaller, Melinda Guzman-Harty, Theresa Siu-Ling Wai Lee, Lisa Ann Reaves, Jin-Zhou Liu
  • Water-miscible esters of mono- and diglycerides having antimicrobial activity and their use in inhibiting infection
    Patent number: 5981587
    Abstract: A process of treating infection by a pathogenic microorganism in a subject in need of such treatment including the step of administering to the subject an effective antimicrobial amount of diacetyltartaric acid esters of mono- and diglycerides is provided. Pharmaceutical compositions containing diacetyltartaric acid esters of mono- and diglycerides as an active antimicrobial agent are also provided.
    Type: Grant
    Filed: July 31, 1996
    Date of Patent: November 9, 1999
    Assignee: Abbott Laboratories
    Inventors: Melinda Guzman-Harty, Milo Duane Hilty, Steven N. Anderson, Joseph Schaller, Terry Bruce Mazer, Theresa Siu-Ling Wai Lee, Lisa Ann Reaves, Jin-Zhou Liu
  • Nutritional formulations containing water-miscible lipid derivatives as antibacterial agents
    Patent number: 5958974
    Abstract: A nutritional formulation containing bactericidal amounts of diacetyltartaric acid esters of mono- and diglycerides is provided. A process of inhibiting bacterial infections including the step of feeding the nutritional composition to a subject is also provided.
    Type: Grant
    Filed: July 31, 1996
    Date of Patent: September 28, 1999
    Assignee: Abbott Laboratories
    Inventors: Steven N. Anderson, Milo Duane Hilty, Terry Bruce Mazer, Joseph Schaller, Melinda Guzman-Harty, Theresa Sui-Ling Wai Lee, Lisa Ann Reaves, Jin-Zhou Liu
  • Water-miscible esters of monoglycerides having antimicrobial activity
    Patent number: 5912372
    Abstract: The present invention provides water-miscible lipid derivatives effective to inhibit the infectious activity of pathogenic microorganisms. Preferred water-miscible lipid derivatives are diacetyltartaric acid esters of monoglycerides wherein 90 percent or more of the fatty acid content is accounted for by a single fatty acid. The fatty acid component preferably contains from 8 to 24 and, more preferably, from about 10 to about 20 carbon atoms. The fatty acid can be saturated, unsaturated or hydroxylated.
    Type: Grant
    Filed: July 29, 1997
    Date of Patent: June 15, 1999
    Assignee: Abbott Laboratories
    Inventors: Terry Bruce Mazer, Steven N. Anderson, Melinda Guzman-Harty, Milo Duane Hilty, Theresa Sui-Ling Wai lee, Joseph Schaller, Jin-Zhou Liu
  • Water-miscible esters of mono--and diglycerides having antibacterial activity and their use in inhibiting infection
    Patent number: 5908862
    Abstract: A process of treating a bacterial infection in a subject in need of such treatment including the step of administering to the subject an effective bactericidal amount of diacetyltartaric acid esters of mono- and diglycerides is provided. Pharmaceutical compositions containing diacetyltartaric acid esters of mono- and diglycerides as an active bactericidal agent are also provided.
    Type: Grant
    Filed: July 31, 1996
    Date of Patent: June 1, 1999
    Assignee: Abbot Laboratories
    Inventors: Theresa Siu-Ling Wai Lee, Joseph Schaller, Steven N. Anderson, Terry Bruce Mazer, Milo Duane Hilty, Melinda Guzman-Harty, Jonathan Allan Meulbroek, Patricia Joan Ewing, Jin-Zhou Liu
  • Nutritional formulations containing water-miscible lipid derivatives as anti-microbial agents
    Patent number: 5866606
    Abstract: A nutritional formulation containing an amount of diacetyltartaric acid esters of mono- and diglycerides effective to inhibit the infectious activity of pathogenic microorganisms is provided. A process of inhibiting the infectious activity of pathogenic microorganisms including the step of feeding the nutritional composition to a subject is also provided.
    Type: Grant
    Filed: July 2, 1997
    Date of Patent: February 2, 1999
    Assignee: Abbott Laboratories
    Inventors: Joseph Schaller, Steven N. Anderson, Terry Bruce Mazer, Milo Duane Hilty, Melinda Guzman-Harty, Theresa Siu-Ling Wai Lee, Tammy Marie Bowman, Jill M. Lamm, Jin-Zhou Liu
  • Inhibition of infection of mammalian cells by respiratory syncytial virus
    Patent number: 5538952
    Abstract: The infection of mammalian cells by RSV may be inhibited by native human .beta.-casein, a recombinant form of human .beta.-casein, and hydrolysates of both. The human .beta.-casein or hydrolysate may be contained in a liquid enteral nutritional product such as an infant formula. The enteral nutritional product may be used, for example, in the prevention and treatment of respiratory tract infection in infants. The human .beta.-casein or hydrolysate may also be administered as a throat spray or nasally using drops or a spray.
    Type: Grant
    Filed: May 26, 1994
    Date of Patent: July 23, 1996
    Assignee: Abbott Laboratories
    Inventors: Pradip Mukerji, Amanda E.-Y. Seo, Steven N. Anderson, Joseph P. Schaller
  • Product for inhibition of infection of mammalian cells by respiratory syncytial virus
    Patent number: 5506209
    Abstract: The infection of mammalian cells by RSV may be inhibited by native human .beta.-casein, a recombinant form of human .beta.-casein, and hydrolysates of both. The human .beta.-casein or hydrolysate may be contained in a liquid enteral nutritional product such as an infant formula. The enteral nutritional product may be used, for example, in the prevention and treatment of respiratory tract infection in infants. The human .beta.-casein or hydrolysate may also be administered as a throat spray or nasally using drops or a spray.
    Type: Grant
    Filed: May 26, 1994
    Date of Patent: April 9, 1996
    Assignee: Abbott Laboratories
    Inventors: Pradip Mukerji, Amanda E. Seo, Steven N. Anderson, Joseph P. Schaller